Page last updated: 2024-08-26

va 061 and veratramine

va 061 has been researched along with veratramine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C1
Ashim, J; Beak, SM; Cho, GJ; Choi, SK; Han, JE; Jeong, H; Jeong, J; Kim, HY; Kim, W; Lee, SW; Lee, YH; Park, JK; Park, S; Ryoo, ZY; Yu, W1

Other Studies

2 other study(ies) available for va 061 and veratramine

ArticleYear
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
    Chemistry & biology, 2015, Jul-23, Volume: 22, Issue:7

    Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic

2015
Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/ATR Pathway in Androgen-Independent Prostate Cancer.
    The American journal of Chinese medicine, 2023, Volume: 51, Issue:5

    Topics: Androgens; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt

2023